---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-008377"
form_type: "8-K"
ticker: "DMAA"
cik: "0002028614"
company_name: "Drugs Made In America Acquisition Corp."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:56:23.846268+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Drugs Made In America Acquisition Corp. closes $200M IPO, deposits $201M in trust

## Summary
- Closed IPO of 20,000,000 units at $10.00 per unit for gross proceeds of $200 million.
- Simultaneous private placement of 400,000 units to sponsor for $4 million, bringing total trust to $201 million.
- Units trade on Nasdaq under DMAAU; ordinary shares (DMAA) and rights (DMAAR) to trade separately later.
- Clear Street acted as sole book-running manager; offering made under effective S-1 registration statement.
- Underwriters have 45-day option for up to 3M additional units to cover over-allotments.

## SEC filing metadata
- accession: 0001213900-25-008377
- form_type: 8-K
- ticker: DMAA
- cik: 0002028614
- company_name: Drugs Made In America Acquisition Corp.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/0001213900-25-008377-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea0229135-8k_drugs.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-008377
- JSON: https://secwatch.observer/filing/0001213900-25-008377.json
- Plain text: https://secwatch.observer/filing/0001213900-25-008377.txt

## Key facts
- Governance Changes
  Drugs Made In America Acquisition Corp.: Adopted Second Amended and Restated Memorandum and Articles of Association in connection with the IPO (effective 2025-01-07).
  - Change: charter amendment
  - Effective: 2025-01-07
  source text: On January 7, 2025, and in connection with the IPO, the Company adopted its Second Amended and Restated Memorandum and Articles of Association.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/0001213900-25-008377-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.